Joint Venture

BPCL's new joint venture with Shell and Tiki Tar isn't just a deal—it's a strategic move to dominate India's high-value infrastructure materials market.

BT and Verizon are spinning off their international units into a $4B joint venture. The move allows both to concentrate on home markets while creating a new powerhouse for AI-era global enterprise connectivity.

Mint Inc. and YAS Digital Group are launching a joint venture to insure AI. Can their data-driven model unlock the next wave of automation in Asia?

A pioneering partnership in Hong Kong is embedding insurance directly into robots, aiming to solve the biggest hurdle to automation and redefine the industry.

Holtec and EDF unveil a plan to build four SMR-300 nuclear reactors at a former UK coal plant, a key step in Britain's energy security strategy.

At Eurosatory 2026, Czechoslovak Group unveiled a wave of new armor, air defense systems, and strategic alliances reshaping Europe's industrial landscape.

With a landmark joint venture in China, Carbios is moving its enzymatic recycling from the lab to the world's largest market. This is a critical test of its licensing model and a blueprint for global expansion.

A Sino-European venture is building the Kingdom's first world-class battery factory, a pivotal move to fuel Vision 2030 and redefine its energy future.

Canadian AI firm GreenCore Solutions partners with an Australian VC to unleash its AI agent fleet on Asia's massive beauty and CPG procurement landscape.

Cincinnati Children's and Parkview Health finalize a landmark agreement, promising to reduce travel for families and reshape the regional healthcare market.

Adaptive Biotechnologies' new debt offering is more than a financial tune-up; it's a calculated move to sever a costly royalty deal and arm its star MRD division for a separate future.

As JetZero breaks ground on a factory set to create 14,500 jobs, its partnership with Deloitte aims to solve a critical problem: who will fill them?

Eos is asking shareholders to fund a pivotal venture for US energy storage. But is the promise of long-term growth worth the immediate cost of dilution?

This isn't just a movie night. Mötley Crüe's one-night screening of 'The Dirt' reveals a sophisticated strategy where cinemas become powerful marketing engines.

A massive Q1 profit, driven by a one-time deal, conceals a revenue drop and a critical systems failure, raising questions about the retailer’s core health.

How an 8(a) small business leveraged a joint venture to land a massive cybersecurity contract, revealing a new strategy for success in federal healthcare IT.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.